Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy A Yap

Showing results (71-80 of 260) with videos related to

Pageof 26
Sort By:
Trends in Pharmacological Sciences|November 23, 2016
Towards Precision Medicine in the Clinic: From Biomarker Discovery to Novel TherapeuticsDearbhaile C Collins, Raghav Sundar, Joline S J Lim, et al.
Current Opinion in Pharmacology|July 16, 2008
Targeting CYP17: established and novel approaches in prostate cancerTimothy A Yap, Craig P Carden, Gerhardt Attard, et al.
Expert Opinion on Investigational Drugs|July 23, 2011
Targeting the insulin-like growth factor signaling pathway: figitumumab and other novel anticancer strategiesTimothy A Yap, David Olmos, Lulama Rhoda Molife, et al.
Journal of Immunotherapy and Precision Oncology|June 6, 2022
The Promise of Poly(ADP-Ribose) Polymerase (PARP) Inhibitors in GliomasNazanin Majd, Timothy A Yap, W K Alfred Yung, et al.
Cancer Journal (Sudbury, Mass.)|December 14, 2021
Development of Next-Generation Poly(ADP-Ribose) Polymerase 1-Selective InhibitorsNatalie Y L Ngoi, Elisabetta Leo, Mark J O'Connor, et al.
Current Opinion in Oncology|April 6, 2012
Targeting the DNA damage response in oncology: past, present and future perspectivesBristi Basu, Timothy A Yap, L Rhoda Molife, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 30, 2023
Aligning Germline Cancer Predisposition With Tumor-Based Next-Generation Sequencing for Modern Oncology Diagnosis, Interception, and Therapeutic DevelopmentTimothy A Yap, Zsofia K Stadler, Leigh Anne Stout, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 30, 2009
Targeting the PI3K/AKT pathway for the treatment of prostate cancerDebashis Sarker, Alison H M Reid, Timothy A Yap, et al.
Biomarkers in Medicine|December 13, 2016
Emerging biomarkers for PD-1 pathway cancer therapyJoline Sj Lim, Raghav Sundar, Maxime Chénard-Poirier, et al.
Drugs|July 13, 2024
Targeting DNA Damage Response Deficiency in Thoracic CancersAleksandra Bzura, Jake B Spicer, Sean Dulloo, et al.
Pageof 26

Showing results (71-80 of 260) with videos related to

Sort By:
Pageof 26
Trends in Pharmacological Sciences|November 23, 2016
Towards Precision Medicine in the Clinic: From Biomarker Discovery to Novel TherapeuticsDearbhaile C Collins, Raghav Sundar, Joline S J Lim, et al.
Current Opinion in Pharmacology|July 16, 2008
Targeting CYP17: established and novel approaches in prostate cancerTimothy A Yap, Craig P Carden, Gerhardt Attard, et al.
Expert Opinion on Investigational Drugs|July 23, 2011
Targeting the insulin-like growth factor signaling pathway: figitumumab and other novel anticancer strategiesTimothy A Yap, David Olmos, Lulama Rhoda Molife, et al.
Journal of Immunotherapy and Precision Oncology|June 6, 2022
The Promise of Poly(ADP-Ribose) Polymerase (PARP) Inhibitors in GliomasNazanin Majd, Timothy A Yap, W K Alfred Yung, et al.
Cancer Journal (Sudbury, Mass.)|December 14, 2021
Development of Next-Generation Poly(ADP-Ribose) Polymerase 1-Selective InhibitorsNatalie Y L Ngoi, Elisabetta Leo, Mark J O'Connor, et al.
Current Opinion in Oncology|April 6, 2012
Targeting the DNA damage response in oncology: past, present and future perspectivesBristi Basu, Timothy A Yap, L Rhoda Molife, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 30, 2023
Aligning Germline Cancer Predisposition With Tumor-Based Next-Generation Sequencing for Modern Oncology Diagnosis, Interception, and Therapeutic DevelopmentTimothy A Yap, Zsofia K Stadler, Leigh Anne Stout, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 30, 2009
Targeting the PI3K/AKT pathway for the treatment of prostate cancerDebashis Sarker, Alison H M Reid, Timothy A Yap, et al.
Biomarkers in Medicine|December 13, 2016
Emerging biomarkers for PD-1 pathway cancer therapyJoline Sj Lim, Raghav Sundar, Maxime Chénard-Poirier, et al.
Drugs|July 13, 2024
Targeting DNA Damage Response Deficiency in Thoracic CancersAleksandra Bzura, Jake B Spicer, Sean Dulloo, et al.
Pageof 26